News
Sementis CEO Dr Anne Collins is recipient of DMTC’s Collaboration Award
February 2024 Sementis was delighted to be recognised at the 2024 DMTC Annual Conference, and our CEO Dr Anne Collins...
-
-
News
New Sementis CEO to Advance Vaccine Technology
September 2023 Biotechnology company Sementis will advance its position at the forefront of vaccine technology with the...
-
News
GOOD NEWS FLASH
January 2023 Sementis has exciting news. We’re pleased to announce that we’ve been awarded a $3 million Federal...
-
News
Key steps to advance vaccine manufacturing technology
December 2022 Sementis are grateful and proud to have the support of DMTC Ltd to advance research and development...
-
News
Sementis’ quest for an Australian second-generation COVID-19 vaccine
October 2021 A South Australian start-up biotech company, Sementis Limited, has joined the global quest to develop a...
-
News
New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses
September 2021 Researchers in Australia have developed a coronavirus disease 2019 (COVID-9) vaccine that induced robust...
-
Report
$5.2 million raised to accelerate work on Australian Covid-19 vaccine
MEDIA RELEASE August 2021 Australian biotechnology company Sementis Limited has raised more than $5.2 million to accelerate...
-
News
Adelaide company Sementis will raise $10m to progress its Covid-19 vaccine candidate
August 2021 Adelaide biotech company Sementis is aiming to raise $10m to accelerate work on its next-generation Covid-19...
-
Report
Australia accelerates new COVID-19 vaccine to fight mutant strains
MEDIA RELEASE May 2021 A leading South Australian immunologist has been awarded $3 million from the Federal Government...
-
Report
New Director to Support COVID Vaccine Development at Sementis
April 2021 Adelaide-based Australian biotechnology company Sementis has appointed internationally-renowned Dr Anna...